Skip to main content
. 2019 May 10;42(7):1255–1262. doi: 10.2337/dc19-0009

Table 2.

Treatment-emergent hypoglycemic events

Faster aspart (mealtime)
Faster aspart (postmeal)
IAsp (mealtime)
n % E R n % E R n % E R
Treatment-emergent hypoglycemia
 Severe* 3 1.1 3 0.02 8 3.1 8 0.06 4 1.6 4 0.03
 Severe or BG confirmed 228 87.4 3,583 27.91 227 88.0 3,594 28.15 217 84.1 3,276 25.66
 Daytime 226 86.6 3,187 24.82 224 86.8 3,117 24.42 217 84.1 2,963 23.21
 Nocturnal 112 42.9 396 3.08 125 48.4 477 3.74 104 40.3 313 2.45
Meal-related severe or BG-confirmed hypoglycemia
 Within 1 h after a meal 64 24.5 119 0.93 46 17.8 66 0.52 62 24.0 105 0.82
 Within 2 h after a meal 161 61.7 717 5.58 136 52.7 505 3.96 147 57.0 601 4.71
 Within 4 h after a meal 200 76.6 1,777 13.84 201 77.9 1,782 13.96 191 74.0 1,668 13.07

Safety analysis set. %, percentage of participants; E, number of events; R, event rate per patient-year of exposure.

Treatment emergent was defined as an event that had onset up to 1 day after the last day of randomized treatment and excluding the events occurring in the run-in period. BG-confirmed hypoglycemia was defined as an episode with a plasma glucose value of <3.1 mmol/L (<56 mg/dL) with or without symptoms consistent with hypoglycemia.

*Severe according to ISPAD 2014.

†Nocturnal severe or BG-confirmed hypoglycemia was statistically significantly different in favor of mealtime IAsp vs. postmeal faster aspart (estimated rate ratio 1.50 [95% CI 1.09; 2.08], P = 0.014).